Recent News

• 12.27.2024 - 180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

Recent Filings

• 02.10.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 8-K Current report
• 02.07.2025 - EFFECT Notice of Effectiveness
• 01.31.2025 - S-1/A General form for registration of securities under the Securities Act of 1933
• 01.28.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 01.10.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 01.10.2025 - D Notice of Exempt Offering of Securities
• 01.03.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 12.31.2024 - 3 Initial statement of beneficial ownership of securities